NCT02784951 (ProHEMS) is a clinical trial of Red blood cells (0Rh D-neg) in Hemorrhagic Shock, sponsored by Haukeland University Hospital.

Who is sponsoring NCT02784951?

NCT02784951 is sponsored by Haukeland University Hospital.

What drugs are being tested in NCT02784951?

Interventions in NCT02784951: Red blood cells (0Rh D-neg), Whole blood (O Rh D-neg K-neg), Freeze dried plasma (LyoPlas).

What condition does NCT02784951 study?

NCT02784951 studies Hemorrhagic Shock.

Is NCT02784951 still recruiting?

NCT02784951 is currently completed. Last updated 10 January 2022.

Last reviewed 2022-01-10 · How we verify

NCT02784951: ProHEMS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Use of Blood and Plasma in Norwegian Physician-staffed Helicopter Emergency Medical System

Completed Last updated 10 January 2022

What this trial tests

trial testing Red blood cells (0Rh D-neg) in Hemorrhagic Shock in 72 participants. Completed in 31 December 2020.

Timeline

1 January 2016

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Haukeland University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	72
Start date	1 January 2016
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	9 locations across Norway

Drugs / interventions tested

Red blood cells (0Rh D-neg) — full drug profile →
Whole blood (O Rh D-neg K-neg) — full drug profile →
Freeze dried plasma (LyoPlas) — full drug profile →

Conditions studied

Hemorrhagic Shock — all drugs for Hemorrhagic Shock →

Sponsor

Haukeland University Hospital

Who can join

Eligibility, any sex, with Hemorrhagic Shock. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this study is to evaluate the use of RBC, FDP, WB in the treatment of exsanguinating patients by physician-staffed emergency medical services in Norway, with focus on prehospital transfusion complications and safety.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Implementation of a low-titre whole blood transfusion program in a civilian helicopter emergency medical service.
Sunde GA, Bjerkvig C, Bekkevold M, Kristoffersen EK, et al · · 2022 · cited 13× · PMID 36494743 · DOI 10.1186/s13049-022-01051-z
Optimizing transfusion strategies in damage control resuscitation: current insights.
Pohlman TH, Fecher AM, Arreola-Garcia C. · · 2018 · cited 5× · PMID 30154676 · DOI 10.2147/jbm.s165394

Verify or expand the search:

Other recruiting trials for Hemorrhagic Shock

Currently open trials in the same condition.

NCT02880163 — REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam · NA · recruiting
NCT07105904 — Biological and Clinical Relevance of Quantra Viscoelastic Hemostatic Assay in Hemorrhagic Cardiac Surgery · active not recruiting
NCT06070350 — Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children · Phase 3 · recruiting

Other Haukeland University Hospital trials

Trials by the same sponsor.

NCT07450105 — Intensive Dialectical Behavior Therapy for Self-Harm and Suicidal Behavior in Youth: A Pilot Study · NA · not yet recruiting
NCT07450092 — Prehospital Use of Forced Air Warming · NA · enrolling by invitation
NCT07268716 — Assess the Efficacy of Tailored Patient Information and Voluntary Patient-managed Outpatient Digital Follow-up (I-POD) a · NA · not yet recruiting
NCT07392697 — The Intravenous Amino Acid Therapy for Vascular Rigidity in End Stage Renal Disease · NA · not yet recruiting
NCT07304219 — Physical Activity Based Treatment for Youth With Depression and Anxiety · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02784951 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Haukeland University Hospital
Last refreshed: 10 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02784951.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing